Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F9SG
|
||||
| Former ID |
DAP001224
|
||||
| Drug Name |
Dexfenfluramine
|
||||
| Synonyms |
Acino; Adifax; Adipomin; DEXFENFLURAN; Dexafenfluramine; Dexfenfluramina; Dexfenfluraminum; Dextrofenfluramine; Fenfluramina; Fenfluramine; Fenfluraminum; Isomeride; Obedrex; Pesos; Ponderex; Rotondin; Dexfenfluramina [Spanish]; Dexfenfluraminum [Latin]; Fenfluramina [DCIT]; Fenfluramine hydrochloride; Levofenfluramine [INN]; Ponderax PA; S 768; D-Fenfluramine; Dexfenfluramine (INN); Dexfenfluramine [INN:BAN]; Fenfluramine (INN); Fenfluramine [INN:BAN]; Fenfluraminum [INN-Latin]; Ponderax (TN); Redux (TN); Fenfluramine, (+-)-Isomer; N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine; D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine; N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine;N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine; N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-(9CI); Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-(9CI); Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-(9CI); (+)-Fenfluramine; (+-)-Fenfluramine; (+/-)-Fenfluramine hydrochloride; (2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; (S)-Fenfluramine; (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane; 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane; 2-Ethylamino-1-(3-trifluoromethylphenyl)propane; 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Obesity [ICD9: 278; ICD10:E66] | Withdrawn from market | [537068] | ||
| Therapeutic Class |
Appetite Depressants
|
||||
| Company |
Wyeth Pharmaceuticals
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H16F3N
|
||||
| Canonical SMILES |
CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
|
||||
| InChI |
1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1
|
||||
| InChIKey |
DBGIVFWFUFKIQN-VIFPVBQESA-N
|
||||
| CAS Number |
CAS 3239-44-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| SuperDrug ATC ID |
A08AA04
|
||||
| SuperDrug CAS ID |
cas=003239449
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [536335] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.